期刊
JOURNAL OF IMMUNOLOGY
卷 188, 期 9, 页码 4278-4288出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1101291
关键词
-
类别
资金
- National Institutes of Health [HL64560, RR13601]
The possibility that simultaneous expansion of T regulatory cells (Treg) and T effector cells early postinfection can confer some immunological benefits has not been studied. In this study, we tested the hypothesis that early, simultaneous cytokine expansion of Treg and T effector cells in a tissue infection site can allow these T cell populations to act in concert to control tissue inflammation/damage while containing infection. IL-2 treatments early after Mycobacterium tuberculosis infection of macaques induced simultaneous expansion of CD4(+)CD25(+)Foxp3(+) Treg, CD8(+)CD25(+)Foxp3(+) T cells, and CD4(+) T effector/CD8(+) T effector/V gamma 2V delta 2 T effector populations producing anti-M. tuberculosis cytokines IFN-gamma and perforin, and conferred resistance to severe TB inflammation and lesions. IL-2-expanded Fox3(+) Treg readily accumulated in pulmonary compartment, but despite this, rapid pulmonary trafficking/accumulation of IL-2-activated T effector populations still occurred. Such simultaneous recruitments of IL-2 expanded Treg and T effector populations to pulmonary compartment during M. tuberculosis infection correlated with IL-2-induced resistance to TB lesions without causing Treg-associated increases in M. tuberculosis burdens. In vivo depletion of IL-2-expanded CD4(+)Foxp3(+) Treg and CD4(+) T effectors during IL-2 treatment of M. tuberculosis-infected macaques significantly reduced IL-2-induced resistance to TB lesions, suggesting that IL-2 expanded CD4(+) T effector cells and Treg contributed to anti-TB immunity. Thus, IL-2 can simultaneously activate and expand T effector cells and Fox3(+) Treg populations and confer resistance to severe TB without enhancing M. tuberculosis infection. The Journal of Immunology, 2012, 188: 4278-4288.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据